StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · TRLV·Healthcare

Trulieve Cannabis Corp. Stock Analysis & AI Score

Trulieve Cannabis Corp. (TRLV) has an ST Score of 63.0 (B), driven by its Sentiment (A+) and held back by its Growth (C-). Analysts rate it Buy with a $15.00 price target (+22.2% upside).

Market Closed
$12.27
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
63
ST Score
63.0/100B

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

TRLV
63.0out of 100
Grade B

Trulieve Cannabis Corp. (TRLV) has an ST Score of 63.0 (B), driven by its Sentiment (A+) and held back by its Growth (C-). Analysts rate it Buy with a $15.00 price target (+22.2% upside).

Strongest
SentimentA+
Weakest
GrowthC-
All factor grades
  • SentimentA+
  • MomentumA-
  • ProfitabilityB+
  • ValuationB-
  • Financial StrengthB-
  • ForecastB-
  • GrowthC-
  • Piotroski5/9
Score methodology
Press Releases

Contact

TRLV stock: frequently asked questions

What is TRLV's ST Score?

Trulieve Cannabis Corp. (TRLV) has an ST Score of 63.0 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is TRLV a buy, hold, or sell?

Analysts rate TRLV a Buy, with a price target of $15.00 (+22.2% vs the current price). Our ST Score grades it B (63.0/100). The ST Score is a data-driven signal, not a recommendation.

What are TRLV's factor grades?

Valuation B-, Profitability B+, Financial Strength B-, Momentum A-, Growth C-, Forecast B-, Sentiment A+.

What is TRLV's valuation grade?

Trulieve Cannabis Corp. (TRLV) earns a valuation grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is TRLV's growth grade?

Trulieve Cannabis Corp. (TRLV) earns a growth grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is TRLV's profitability grade?

Trulieve Cannabis Corp. (TRLV) earns a profitability grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is TRLV's financial strength grade?

Trulieve Cannabis Corp. (TRLV) earns a financial strength grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for TRLV?

The average analyst price target for Trulieve Cannabis Corp. (TRLV) is $15.00 from 1 analysts, which is +22.2% versus the recent price of $12.27.

What is TRLV's Piotroski score?

Trulieve Cannabis Corp. (TRLV) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.